The cost of treating addiction from the client's perspective: Results from a multi-modality application of the Client DATCAP

Drug and Alcohol Dependence

Volumn 104, Issue 3, 2009, Pages 241-248

  McCollister, Kathryn E ^a   French, Michael T ^a,b,c   Pyne, Jeffrey M ^d,e   Booth, Brenda ^d   Rapp, Richard ^f   Carr, Carey ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^f WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Addiction treatment; Client DATCAP; Cost analysis; Economic evaluation

Indexed keywords

METHADONE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HOSPITAL CARE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT ATTITUDE; PRIORITY JOURNAL;

ADULT; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 68449100481     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.05.014     Document Type: Article

References (51)

1. Anderson D.W., Bowland B.J., Cartwright W.S., and Bassin G. Service-level costing of drug abuse treatment. J. Subst. Abuse Treat. 15 (1998) 201-211
2. Barnett V., and Lewis T. Outliers in Statistical Data (1994), John Wiley, New York [previous editions 1978, 1984]
3. Batten, H.L., Horgan, C.M., Prottas, J.M., Simon, L.J., Larson, M.J., Elliott, E.A., Bowden, M.L., Lee, M.T., 1992. Drug Services Research Survey: Phase I, final report. Brandeis University, Institute for Health Policy, Waltham, MA.
4. Becker G.S. A theory of the allocation of time. Econ. J. 75 (1965) 493-517
5. Bickel W.K., and Marsch L.A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 96 (2001) 73-86
6. Bradley C.J., French M.T., and Rachal J.V. Financing and cost of standard and enhanced methadone treatment. J. Subst. Abuse Treat. 11 (1994) 433-442
7. Bray J.W., French M.T., Bowland B.J., and Dunlap L.J. The cost of employee assistance programs (EAPs): findings from seven case studies. Employee Assistance Q. 11 (1996) 1-19
8. Butynski W. Drug treatment services: funding and admissions. In: Pickens R.W., Leukefeld C.G., and Schuster C.R. (Eds). Improving Drug Abuse Treatment. NIDA Monograph No. 106 (1991), National Institute on Drug Abuse, Rockville, MD 20-52
9. Caliber and Associates, 1989. Cost-benefit Study of the Navy's Level III Alcohol Rehabilitation Program. Final Report.
10. Cartwright, W.S., Kaple, J.M. (Eds.), 1991. Economic Costs, Cost-effectiveness, Financing, and Community-based Drug Treatment. NIDA Monograph No. 113. National Institute on Drug Abuse, Rockville, MD.
11. Cox, N.J., 1998. WINSOR: Stata Module to Winsorize a Variable. Statistical Software Components S361402. [Revised 09 August 2006]. Department of Economics, Boston College, Boston, MA.
12. Feather P., and Shaw W.D. Estimating the cost of leisure time for recreation demand models. J. Environ. Econ. Manage. 38 (1999) 49-65
13. Flynn P.M., Broome K.M., Beaston-Blaakman A., Knight D.K., Horgan C.M., and Shepard D.S. Treatment cost analysis tool (TCAT) for estimating costs of outpatient treatment services. Drug Alcohol Depend. 100 1-2 (2009) 47-53 1
14. Frank R.G., and McGuire T.G. Estimating costs of mental health and substance abuse coverage. Health Aff. 14 (1995) 102-115
15. French M.T. Drug Abuse Treatment Cost Analysis Program (DATCAP): Program version User's Manual. eighth edition (2002), University of Miami, Coral Gables, FL
16. French M.T. Drug Abuse Treatment Cost Analysis Program (DATCAP): Program version. eighth edition (2002), University of Miami, Coral Gables, FL
17. French M.T., Dunlap L.J., Zarkin G.A., and Karuntzos G.T. The costs of an enhanced employee assistance program (EAP) intervention. Eval. Program Plann. 21 (1998) 227-236
18. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., and McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment: the Drug Abuse Treatment Cost Analysis Program (DATCAP). J. Subst. Abuse Treat. 14 (1997) 1-11
19. French M.T., and McGeary K.A. Estimating the economic cost of substance abuse treatment. Health Econ. 6 (1997) 539-544
20. French M.T., Popovici I., and Tapsell L. The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement. J. Subst. Abuse Treat. 35 (2008) 462-469
21. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York
22. Goodman A.C., Holder H.D., Nishiura E., and Hankin J. An analysis of short-term alcoholism treatment cost functions. Med. Care 30 (1992) 795-809
23. Goodman A.C., Nishiura E., Hankin J.R., Holder H.D., and Tilford J.M. Long-term alcoholism treatment costs. Med. Care Res. Rev. 53 (1996) 441-464
24. Harwood, H.J., Napolitano, D.M., Christensen, P.L., Collins, J.J., 1984. Economic Costs to Society of Alcohol and Drug Abuse and Mental Illness: 1980. Report to the Alcohol, Drug Abuse, and Mental Health Administration. Research Triangle Institute, Research Triangle Park, NC.
25. Heckman J.J. Shadow prices, market wages, and labor supply. Econometrica 42 (1974) 679-694
26. Holder H.D. Alcoholism treatment and potential health care cost saving. Med. Care 25 (1987) 52-71
27. Holder H.D., and Blose J.O. Typical patterns and cost of alcoholism treatment across a variety of populations and providers. Alcohol Clin. Exp. Res. 15 (1991) 190-195
28. Horgan C. Cost of drug treatment programs: preliminary findings from the 1990 drug services research survey. Presented at the NIDA National Conference on Drug Abuse Research and Practice. Washington, DC, January (1991)
29. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., and Ginzburg H.M. Drug Abuse Treatment: A National Study of Effectiveness (1989), University of North Carolina Press, Chapel Hill, NC
30. Kellogg S., and Kreek M.J. On blending practice and research: the search for commonalities in substance abuse treatment. Subst. Abuse 27 1-2 (2006) 9-24
31. Kleinman L., Lowin A., Flood E., Gandhi G., Edgell E., and Revicki D. Costs of bipolar disorder. Pharmacoeconomics 21 (2003) 601-622
32. Moffitt R. The Tobit model, hours of work and institution constraints. Rev. Econ. Statist. 64 (1982) 510-515
33. Pauly M.V., Nicholson S., Xu J., Polsky D., Danzon P.M., Murray J.F., and Berger M.L. A general model of the impact of absenteeism on employers and employees. Health Econ. 11 (2002) 221-231
34. Propper C., Croxson B., and Shearer A. Waiting times for hospital admissions: the impact of GP fundholding. J. Health Econ. 21 (2002) 227-252
35. Pyne J.M., French M.T., McCollister K.E., Tripathi S., Rapp R., and Booth B. Quality-adjusted life years (QALYS) and substance use disorders. Addiction 103 (2008) 1331-1332
36. Rapp R.C., Carr C.A., Lane D., Redko C., and Carlson R.G. Development of the pretreatment readiness scale for substance abusers: modification of an existing motivation assessment. Subst. Abuse 29 (2008) 39-50
37. Rice D.P., Kelman S., and Miller L.S. The economic burden of mental illness. Hosp. Community Psychiatry 43 (1992) 1227-1232
38. Rice, D.P., Kelman, S., Miller, L.S., Dunmeyer, S., 1990. The Economic Costs of Alcohol and Drug Abuse and Mental Illness: 1985. DHHS Publication No. (ADM) 90-1694.
39. Roebuck M.C., French M.T., and McLellan A.T. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program. J. Subst. Abuse Treat. 25 (2003) 51-57
40. Roll J.M. Contingency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 102 Suppl. 1 (2007) 114-120
41. Rosenbach M.L., and Huber J.H. Utilization and cost of drug abuse treatment under Medicaid: an in-depth study of Washington State. National Institute on Drug Abuse Services Research Monograph No. 1 (1994) 51-94
42. Royston P. Multiple imputation of missing values. The Stata J. 4 (2004) 227-241
43. Salomé H.J., French M.T., Miller M., and McLellan A.T. Estimating the client costs of addiction treatment: first findings from the Client DATCAP. Drug Alcohol Depend. 71 (2003) 195-206
44. Schafer J.L., and Graham J.W. Missing data: our view of the state of the art. Psychol. Methods 7 (2002) 147-177
45. Substance Abuse and Mental Health Services Administration, 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rep. No. NSDUH Series H-34. DHHS Publication No. SMA 08-4343. Office of Applied Studies, Rockville, MD.
46. Tranmer J.E., Guerriere D.N., Ungar W.J., and Coyte P.C. Valuing patient and caregiver time: a review of the literature. Pharmacoeconomics 23 (2005) 449-459
47. U.S. Department of Labor, Bureau of Labor Statistics, 2008. National Compensation Survey - July 2007. Available at http://www.bls.gov/ncs/ocs/sp/ncbl1035.pdf. (accessed March 20, 2009).
48. U.S. Department of Transportation, Research and Innovative Technology Administration, 2007. Transportation Statistics Annual Report 2007. Bureau of Transportation Statistics, Washington, DC.
49. Zarkin G.A., Cates S.C., and Bala M.V. Estimating the willingness-to-pay for drug abuse treatment: a Pilot Study. J. Subst. Abuse Treat. 18 (2005) 149-159
50. Zarkin G.A., Dunlap L.J., and Homsi G. The substance abuse services cost analysis program (SASCAP): a new method for estimating drug treatment services costs. Eval. Program Plann. 27 (2004) 35-43
51. Zarkin G.A., Dunlap L.J., Wedehase B., and Cowell A.J. The effect of alternative staff time data collection methods on drug treatment service cost estimates. Eval. Program Plann. 31 (2008) 427-435